Avedro presents novel Boost Epi-On corneal CXL data
Non-invasive corneal CXL procedure does not require removal of the epithelium
Priscilla Lynch
Published: Monday, September 16, 2019
AVEDRO showcased early data on its novel Boost Epi-On cross-linking (CXL) technology for the treatment of keratoconus during an educational session at the 37th Congress of the ESCRS yesterday.
Presentations highlighted the positive early clinical experiences of several clinicians from different countries who have evaluated Boost Epi-On CXL, a non-invasive corneal CXL procedure that does not require removal of the epithelium.
The latest-generation technology addresses the limitations of prior epi-on procedures through the addition of supplemental oxygen. This drives oxygen diffusion across the epithelium to enhance CXL, better stabilising and strengthening the cornea and ultimately halting or slowing keratoconus progression, yesterday’s educational session heard.
The procedure is thus easier, with less postoperative ocular discomfort and a faster recovery time. It is also safer with less risk of complications and preserves corneal thickness as well as improving visual acuity, speakers said.
Speaking to EuroTimes, Avedro CEO Reza Zadno PhD noted that keratoconus is a disease that particularly impacts young people, “and treating and halting its progression leads to a major quality of life improvement for these patients”.
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.